Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasm, Residual 2Neoplasm Metastasis 1Melanoma 1Mediastinal Neoplasms 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Burkitt Lymphoma 1

Interventions

Nivolumab 5aldesleukin 3Ipilimumab 3Blood Specimen Collection 3relatlimab 2Vemurafenib 2Immune Checkpoint Inhibitors 2trametinib 1technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1technetium Tc 99m nanocolloid 1sargramostim 1pembrolizumab 1pasireotide 1encorafenib 1dabrafenib 1binimetinib 1Vindesine 1Standard of Care 1Specimen Handling 1Sevoflurane 1Propofol 1Pharmaceutical Preparations 1Patient-Specific Modeling 1Isoflurane 1Interleukins 1Interleukin-2 1Granulocyte-Macrophage Colony-Stimulating Factor 1Fibrin Tissue Adhesive 1Etanercept 1Desflurane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Melanoma × Vindesine × Clear all
NCT00226473 2006-06-21

Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma

Dermatologic Cooperative Oncology Group

Phase 4 Unknown
200 enrolled
Dermatologic

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡